A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder
暂无分享,去创建一个
Brian C. Davis | P. Puri | J. Meador | J. Bajaj | P. Gillevet | M. Sikaroodi | J. Wade | M. Fuchs | L. Thacker | A. Fagan | E. Gavis | S. Patel
[1] Keir Martin. Dependence , 2021, Cambridge Encyclopedia of Anthropology.
[2] D. Brenner,et al. Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder , 2020, Frontiers in Physiology.
[3] R. Frozza,et al. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication , 2020, Frontiers in Endocrinology.
[4] S. Taylor-Robinson,et al. Microbial Functional Change is Linked with Clinical Outcomes after Capsular Fecal Transplant in Cirrhosis. , 2019, JCI insight.
[5] M. Osman,et al. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial , 2019, Hepatology.
[6] Miriam H. Huntley,et al. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. , 2019, The New England journal of medicine.
[7] M. Osman,et al. Donor Screening for Fecal Microbiota Transplantation. , 2019, The New England journal of medicine.
[8] N. Bray. The microbiota–gut–brain axis , 2019 .
[9] K. Faber,et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases , 2019, Front. Immunol..
[10] N. Delzenne,et al. The gut microbiota: A new target in the management of alcohol dependence? , 2019, Alcohol.
[11] S. Sarin,et al. Microbiome as a therapeutic target in alcohol-related liver disease. , 2019, Journal of hepatology.
[12] J. Bajaj,et al. Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis. , 2019, Gastroenterology.
[13] J. Bajaj. Alcohol, liver disease and the gut microbiota , 2019, Nature Reviews Gastroenterology & Hepatology.
[14] Lanjuan Li,et al. Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study , 2018, Front. Microbiol..
[15] Xiaoli Wu,et al. Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis , 2018, Front. Integr. Neurosci..
[16] G. Szabo. Women and alcoholic liver disease — warning of a silent danger , 2018, Nature Reviews Gastroenterology & Hepatology.
[17] S. Taylor-Robinson,et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial , 2017, Hepatology.
[18] Dmitry S. Ischenko,et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease , 2017, Microbiome.
[19] S. Sarin,et al. Healthy Donor Fecal Microbiota Transplantation in Steroid‐Ineligible Severe Alcoholic Hepatitis: A Pilot Study , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[20] N M Delzenne,et al. The link between inflammation, bugs, the intestine and the brain in alcohol dependence , 2017, Translational Psychiatry.
[21] M. Dekker Nitert,et al. Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy , 2016, Hypertension.
[22] R. Bataller,et al. Biomarkers for monitoring alcohol use , 2016, Clinical liver disease.
[23] G. Addolorato,et al. Treatment of alcohol use disorders in patients with alcoholic liver disease. , 2016, Journal of hepatology.
[24] E. Elinav,et al. Metabolites: messengers between the microbiota and the immune system , 2016, Genes & development.
[25] J. Bajaj,et al. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study , 2016, The American Journal of Gastroenterology.
[26] E. Le Chatelier,et al. Qin et al. reply , 2015, Nature.
[27] R. Mattick,et al. Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis. , 2014, Drug and alcohol dependence.
[28] Sébastien Matamoros,et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity , 2014, Proceedings of the National Academy of Sciences.
[29] Philip Wong,et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver , 2014, Hepatology.
[30] Jürgen Rehm,et al. Global burden of alcoholic liver diseases. , 2013, Journal of hepatology.
[31] C. Huttenhower,et al. Metagenomic biomarker discovery and explanation , 2011, Genome Biology.
[32] G. Nava,et al. Diversity of the autochthonous colonic microbiota , 2011, Gut microbes.
[33] N. Ren,et al. Ethanoligenens harbinense gen. nov., sp. nov., isolated from molasses wastewater. , 2006, International journal of systematic and evolutionary microbiology.
[34] K Weissenborn,et al. Neuropsychological characterization of hepatic encephalopathy. , 2001, Journal of hepatology.
[35] M. Bergner,et al. The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.
[36] K. Nelson,et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. , 2015, Gastroenterology.
[37] J. Westermeyer,et al. Alcohol craving in outpatients with alcohol dependence: rate and clinical correlates. , 2006, Journal of studies on alcohol.